biperiden has been researched along with Nocturnal Wandering in 1 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We assessed in a follow-up study of 4 years (medium, range: 2-7 years) the usefulness of the antiparkinsonian drug biperiden (Akineton©), an acetylcholine antagonist with high affinity for muscarinic M1-type receptors, in four consecutive cases of arousal disorder with sleepwalking and confusional behavior in adolescents and adults with or without epilepsy who did not respond to diazepam, clonazepam or amitriptyline." | 9.16 | Biperiden for treatment of somnambulism in adolescents and adults with or without epilepsy: clinical observations. ( Hodoba, D; Schmidt, D, 2012) |
| "We assessed in a follow-up study of 4 years (medium, range: 2-7 years) the usefulness of the antiparkinsonian drug biperiden (Akineton©), an acetylcholine antagonist with high affinity for muscarinic M1-type receptors, in four consecutive cases of arousal disorder with sleepwalking and confusional behavior in adolescents and adults with or without epilepsy who did not respond to diazepam, clonazepam or amitriptyline." | 5.16 | Biperiden for treatment of somnambulism in adolescents and adults with or without epilepsy: clinical observations. ( Hodoba, D; Schmidt, D, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hodoba, D | 1 |
| Schmidt, D | 1 |
1 trial available for biperiden and Nocturnal Wandering
| Article | Year |
|---|---|
Biperiden for treatment of somnambulism in adolescents and adults with or without epilepsy: clinical observations.
Topics: Adolescent; Adult; Biperiden; Cholinergic Antagonists; Epilepsy; Humans; Male; Middle Aged; Polysomn | 2012 |